-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Bicara Therapeutics Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q3 2023 to Q3 2025.
- Bicara Therapeutics Inc. Income Tax Expense (Benefit) for the quarter ending September 30, 2025 was $40K.
- Bicara Therapeutics Inc. Income Tax Expense (Benefit) for the twelve months ending September 30, 2025 was $343K.
- Bicara Therapeutics Inc. annual Income Tax Expense (Benefit) for 2024 was $180K, a 3500% increase from 2023.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)